
How Litfulo Revolutionizes Alopecia Treatment with FDA Approval
Alopecia areata, an autoimmune disorder causing sudden hair loss, presents a daunting challenge for many. The emergence of Litfulo offers a groundbreaking solution as the first FDA-approved oral treatment for severe cases in both adults and adolescents. By targeting specific enzymes, Litfulo not only curbs immune attacks on hair follicles but also supports significant hair […]
3 minute read